Neurointervention.  2023 Mar;18(1):23-29. 10.5469/neuroint.2022.00458.

Flow Diverter Treatment for Non-Ruptured Carotid Aneurysms: Efficacy and Safety

• López-Callejas O
• Ortiz-Giraldo AF
• Vera DD
• Ramirez-Rojas DA
• Villamizar-Barahona AB
• Ferreira-Prada CA
• Galvis M
• Vargas-Pérez O
• Serrano-Gómez S
• Reyes-Gonzalez A
• Mantilla D

• KMID: 2539943
• DOI: http://doi.org/10.5469/neuroint.2022.00458

Abstract

Purpose
Internal carotid artery (ICA) aneurysm treatment with a flow diverter (FD) has shown an adequate efficacy and safety profile, presenting high complete occlusion or near occlusion rates with low complications during follow-up. The purpose of this study was to evaluate the efficacy and safety of FD treatment in non-ruptured internal carotid aneurysms.
Materials and Methods
This is a retrospective, single-center, observational study evaluating patients diagnosed with unruptured ICA aneurysms treated with an FD between January 1, 2014, and January 1, 2020. We analyzed an anonymized database. The primary effectiveness endpoint was complete occlusion (O’Kelly–Marotta D, OKM-D) of the target aneurysm through 1-year follow-up. The safety endpoint was the evaluation of modified Rankin Scale (mRS) 90 days after treatment, considering a favorable outcome an mRS 0-2.
Results
A total of 106 patients were treated with an FD, 91.5% were women; the mean follow- up was 427.2±144.8 days. Technical success was achieved in 105 cases (99.1%). All patients included had 1-year follow-up digital subtraction angiography control; 78 patients (73.6%) completed the primary efficacy endpoint by achieving total occlusion (OKM-D). Giant aneurysms had a higher risk of not achieving complete occlusion (risk ratio, 3.07; 95% confidence interval, 1.70 - 5.54]). The safety endpoint of mRS 0-2 at 90 days was accomplished in 103 patients (97.2%).
Conclusion
Treatment of unruptured ICA aneurysms with an FD showed high 1-year total occlusion results, with very low morbidity and mortality complications.

Keyword

Endovascular procedures; Aneurysm; Stents; Treatment outcome; Safety; Complications

Reference

1. Brisman JL, Song JK, Newell DW. Cerebral aneurysms. N Engl J Med. 2006; 355:928–939.

2. Rincon F, Rossenwasser RH, Dumont A. The epidemiology of admissions of nontraumatic subarachnoid hemorrhage in the United States. Neurosurgery. 2013; 73:217–222. discussion 212-213.

3. Lv X, Jiang C, Li Y, Yang X, Zhang J, Wu Z. Treatment of giant intracranial aneurysms. Interv Neuroradiol. 2009; 15:135–144.

4. Bonneville F, Sourour N, Biondi A. Intracranial aneurysms: an overview. Neuroimaging Clin N Am. 2006; 16:371–382. vii.

5. Lawton MT, Vates GE. Subarachnoid hemorrhage. N Engl J Med. 2017; 377:257–266.

6. Petridis AK, Kamp MA, Cornelius JF, Beez T, Beseoglu K, Turowski B, et al. Aneurysmal subarachnoid hemorrhage. Dtsch Arztebl Int. 2017; 114:226–236.

7. van Gijn J, Kerr RS, Rinkel GJ. Subarachnoid haemorrhage. Lancet. 2007; 369:306–318.

8. Kundra S, Mahendru V, Gupta V, Choudhary AK. Principles of neuroanesthesia in aneurysmal subarachnoid hemorrhage. J Anaesthesiol Clin Pharmacol. 2014; 30:328–337.

9. D’Souza S. Aneurysmal subarachnoid hemorrhage. J Neurosurg Anesthesiol. 2015; 27:222–240.

10. van Dijk JM, Groen RJ, Ter Laan M, Jeltema JR, Mooij JJ, Metzemaekers JD. Surgical clipping as the preferred treatment for aneurysms of the middle cerebral artery. Acta Neurochir (Wien). 2011; 153:2111–2117.

11. Schievink WI. Intracranial aneurysms. N Engl J Med. 1997; 336:28–40.

12. Lv X, Yang H, Liu P, Li Y. Flow-diverter devices in the treatment of intracranial aneurysms: a meta-analysis and systematic review. Neuroradiol J. 2016; 29:66–71.

13. Becske T, Kallmes DF, Saatci I, McDougall CG, Szikora I, Lanzino G, et al. Pipeline for uncoilable or failed aneurysms: results from a multicenter clinical trial. Radiology. 2013; 267:858–868.

14. Kallmes DF, Hanel R, Lopes D, Boccardi E, Bonafé A, Cekirge S, et al. International retrospective study of the pipeline embolization device: a multicenter aneurysm treatment study. AJNR Am J Neuroradiol. 2015; 36:108–115.

15. Hanel RA, Kallmes DF, Lopes DK, Nelson PK, Siddiqui A, Jabbour P, et al. Prospective study on embolization of intracranial aneurysms with the pipeline device: the PREMIER study 1 year results. J Neurointerv Surg. 2020; 12:62–66.

16. O’kelly CJ, Krings T, Fiorella D, Marotta TR. A novel grading scale for the angiographic assessment of intracranial aneurysms treated using flow diverting stents. Interv Neuroradiol. 2010; 16:133–137.

17. Samuels OB, Joseph GJ, Lynn MJ, Smith HA, Chimowitz MI. A standardized method for measuring intracranial arterial stenosis. AJNR Am J Neuroradiol. 2000; 21:643–646.

18. Brinjikji W, Murad MH, Lanzino G, Cloft HJ, Kallmes DF. Endovascular treatment of intracranial aneurysms with flow diverters: a meta-analysis. Stroke. 2013; 44:442–447.

19. Briganti F, Leone G, Marseglia M, Mariniello G, Caranci F, Brunetti A, et al. Endovascular treatment of cerebral aneurysms using flow-diverter devices: a systematic review. Neuroradiol J. 2015; 28:365–375.